Close

Covidien Acquires CardioDigital Inc. Technology

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

NHS Boards to Explore Joint Working...

In a recent update, two NHS boards to explore...

NHS Performance Standards Tested as Patients...

The NHS in England has remained under relentless pressure...

Thermo Fisher Receives FDA Approval for...

The world leader when it comes to serving science,...

Virtual MRI Imaging with AI Aids...

During the magnetic resonance imaging (MRI) procedures, contrast agents...
Covidien, a leading global supplier of healthcare products, announced the acquisition of technology assets from CardioDigital Inc., a company specializing in the development of advanced signal processing techniques for patient monitoring.

Covidien, a leading global supplier of healthcare products, announced the acquisition of technology assets from CardioDigital Inc., a company specializing in the development of advanced signal processing techniques for patient monitoring. The technology, which will be used by Covidien's Respiratory and Monitoring Solutions business unit, reflects the Company's strong commitment to making investments in clinically relevant product innovations designed to improve patient outcomes. Terms of the transaction were not disclosed.

Joe Almeida, President, Medical Devices, Covidien said, The acquisition of CardioDigital's technology is an exciting opportunity for us to strengthen our patient monitoring business as we partner with our customers to improve outcomes.  We believe that the technology will enable significant improvements in current patient monitoring techniques, resulting in enhanced patient care and safety.

Almeida said, CardioDigital's innovative technology will complement Respiratory and Monitoring Solution's market-leading Nellcor pulse oximetry platform. In addition, This acquisition sets the stage for more of these types of growth opportunities in the future.

Latest stories

Related stories

NHS Boards to Explore Joint Working in Sussex and Surrey

In a recent update, two NHS boards to explore...

NHS Performance Standards Tested as Patients Volume Grows

The NHS in England has remained under relentless pressure...

Virtual MRI Imaging with AI Aids Better Tumor Detection

During the magnetic resonance imaging (MRI) procedures, contrast agents...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back